NCT00777868 - A Dose-Ranging Study Evaluating the Safety and Efficacy of IDP-108 in Patients With Onychomycosis | Biotech Hunter

Enrollment

135

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

April 30, 2009

Study Completion Date

April 30, 2009

Conditions

Onychomycosis

Interventions

DRUG

Low Strength IDP-108

Topical application once a day for 9 months

DRUG

High Strength IDP-108

Topical application once a day for 9 months

DRUG

High Strength IDP-108 under occlusion

Topical application once a day for 9 months

DRUG

Vehicle

Topical application once a day for 9 months

Trial Locations (10)

Unidad de Investigación en Salud, Chihuahua City

Clinical Research Institute, Mexico City

Hospital Central Militar, Mexico City

Hospital General de México, México

"Instituto Dermatólogico de Jalisco Dr. Jose Barba Rubio", Guadalajara

Hospital Dr. Ángel Leaño, Zapopan

MIRC/OCA Hospital, Monterrey

Centro de Dermatología de Monterrey, Monterrey

"Hospital Universitario José E. González", Monterrey

Hospital Ignacio Morones Prieto SLP, San Luis Potosí City